Objectives:To investigate if focused extracorporeal shock wave therapy (f-ESWT) is an effective treatment in a population affected by greater trochanteric pain syndrome (GTPS).Design:Randomized controlled trial, with blind outcome assessors.Setting:Outpatients, University Hospital.Subjects:A total of 50 patients affected by GTPS with gluteal tendinopathy.Interventions:The study group was assigned to receive f-ESWT, the control group received ultrasound therapy (UST).Main measures:We assessed hip pain and lower limb function by means of a numeric rating scale (p-NRS) and the Lower Extremity Functional Scale (LEFS scale), respectively. The first follow-up evaluation (2M-FUP) was performed two?months after the first treatment session, the second (6M-FUP) was carried out six?months later.Results:The mean age of the population was 61.24 (9.26)?years. A marked prevalence of the female sex was recorded (44 subjects, 86%). The statistical analysis showed a significant pain reduction over time for the study group and the control group, the f-ESWT proving to be significantly more effective than UST (P?
Carlisi, E., Cecini, M., Di Natali, G., Manzoni, F., Tinelli, C., & Lisi, C. (2018). Focused extracorporeal shock wave therapy for greater trochanteric pain syndrome with gluteal tendinopathy: a randomized controlled trial. Clinical Rehabilitation, 33(4), 670-680. https://doi.org/10.1177/0269215518819255